Psychiatry & Neurology, Neuromuscular Medicine · St Petersburg, FL
NPI
1871738948
Since 2008
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1201 5th Ave N, Suite 202
St Petersburg, FL, 33705
Phone (727) 820-7701
Groups this clinician bills Medicare through
Medicare paid, 2024
$169K
13,369 services
Medicare patients, 2024
252
Average age 72
Drug cost, 2024
$3.2M
2,010 prescriptions
Company payments, 2025
$50K
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Rosario-Prieto was code J0585 (injection, onabotulinumtoxina, 1 unit), 8,849 times for 16 patients. In total Michael Rosario-Prieto billed 13,369 services in 56 codes, and Medicare paid $169K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 8,849 | 16 | $4.95 | $44K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,821 | 14 | $0.11 | $191 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 131 | 97 | $11.81 | $1,547 |
| 99214 Office E&M - Established | Office | 112 | 86 | $84.33 | $9,445 |
| 99215 Office E&M - Established | Office | 63 | 50 | $124.44 | $7,840 |
| 95886 Electrical Nerve Conductivity | Office | 49 | 42 | $68.87 | $3,374 |
| 99204 Office E&M - New | Office | 38 | 38 | $116.41 | $4,424 |
| 99213 Office E&M - Established | Office | 31 | 30 | $60.42 | $1,873 |
| 99205 Office E&M - New | Office | 29 | 29 | $165.99 | $4,814 |
| 95911 Electrical Nerve Conductivity | Office | 21 | 21 | $146.96 | $3,086 |
| 64405 Musculoskeletal | Office | 20 | 12 | $82.38 | $1,648 |
| 95885 Electrical Nerve Conductivity | Office | 18 | 13 | $38.44 | $692 |
| 95910 Electrical Nerve Conductivity | Office | 12 | 12 | $118.63 | $1,424 |
By year: 2022 $234K for 7,223 services; 2023 $195K for 9,926 services; 2024 $169K for 13,369 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Rosario-Prieto prescribed most often to Medicare patients was Gabapentin, with 247 prescriptions and refills. In total Michael Rosario-Prieto wrote 2,010 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 247 | 359 | 46 | $3,990 |
| Pyridostigmine Bromide Generic | 105 | 159 | 23 | $9,051 |
| Prednisone Generic | 102 | 119 | 17 | $463 |
| Duloxetine Hcl Generic | 88 | 133 | 18 | $1,968 |
| Aimovig Autoinjector Erenumab-Aooe | 85 | 103 | Under 11 | $77K |
| Atorvastatin Calcium Generic | 65 | 129 | 13 | $682 |
| Sumatriptan Succinate Generic | 57 | 60 | Under 11 | $3,828 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 54 | 54 | Under 11 | $306K |
| Primidone Generic | 54 | 68 | Under 11 | $1,111 |
| Memantine Hcl Generic | 52 | 71 | Under 11 | $1,042 |
| Clopidogrel Clopidogrel Bisulfate | 51 | 99 | Under 11 | $320 |
| Baclofen Generic | 42 | 75 | 12 | $491 |
| Donepezil Hcl Generic | 37 | 55 | Under 11 | $234 |
| Cyclobenzaprine Hcl Generic | 36 | 38 | Under 11 | $133 |
| Radicava Ors Edaravone | 36 | 36 | Under 11 | $506K |
Brand drugs: 431 claims; generic drugs: 1,579 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Rosario-Prieto $50K ($50K in general payments such as food, travel and fees) from 32 companies. The largest payer was UCB, Inc. with $40K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 59 | $40K |
| Argenx US, Inc. ARGX | 10 | $7,274 |
| Abbvie Inc. ABBV | 14 | $282 |
| Janssen Biotech, Inc. JNJ | 5 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $184 |
| Pfizer Inc. PFE | 10 | $166 |
| Genentech USA, Inc. ROG.SW | 6 | $144 |
| Biogen, Inc. BIIB | 6 | $143 |
| Vanda Pharmaceuticals Inc. VNDA | 6 | $138 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.